Three years experience with glibenclamide in the maturity onset diabetes mellitus. | [Pakistan Journal of Medical Research • 1974]

Author(s):

1. Zulfiqar Haider: Research Cell, Fatima Jinnah Medical College, Lahore, Pakistan

2. Surraiya Obaidullah: Research Cell, Fatima Jinnah Medical College, Lahore, Pakistan

3. Farhat Jabeen: Research Cell, Fatima Jinnah Medical College, Lahore, Pakistan

4. Fayyazuddin: Research Cell, Fatima Jinnah Medical College, Lahore, Pakistan

Abstract:

Two hundred and eighty two patients with maturity onset diabetes mellitus were treated with Glibenclamide and followed up over a period ranging from three months up to 3 years. Excellent to good control was achieved in 179 out of 282 cases. A trial of Glibenclamide in 45 secondary failures on the sulphenylurea showed an improvement in status to satisfactory level in about 50% over the period of observation. Over three years period, the drug has been without any serious toxic effect in the dosage recommended.

Page(s): 15-20

DOI: DOI not available

Published: Journal: Pakistan Journal of Medical Research, Volume: 13, Issue: 1, Year: 1974

Keywords:

Keywords are not available for this article.

References:

References are not available for this document.

Citations

Citations are not available for this document.

Citations

Downloads

Views